Longeveron Inc. (NASDAQ: LGVN) held a Type C meeting with the U.S. Food and Drug Administration in late March regarding ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE